Radioisotope bone scanning is a sensitive indicator of metastatic disease. Localization of the hot spot for biopsy is difficult. Today, a hand-held gamma probe enables the surgeon intraoperatively to accomplish the localization procedure easily. As this technique is described in American literature exclusively, more recent European findings is presented here. During one month two patients were diagnosed with breast cancer. Bone scanning disclosed minor hot spots in the ribs. On the day of surgical biopsy the localization of the hot spots was guided by a gamma probe. For the biopsy a dermal punch biopsy needle was employed, and fine needle aspiration biopsies were also taken.
INTRODUCTION
When planning for optimal treatment of a malignant disease, correct diagnosis and staging are critical. In breast cancer osseous metastases are not uncommon. In clinical work radioisotope bone scan is a sensitive indicator of metastatic disease. However, a positive bone scan is a non-specific finding, especially when the objective is the ribs where the plain radiographs are not always able to extend the information about the diseased parts of the rib. Robinson et al. (1) present a list of normal structures, soft tissue abnormalities, bony abnormalities, benign bone tumours, primary malignant bone tumours and metastatic tumours, which appear in a similar manner on a bone scan. Another way to evaluate bone lesions is by the means of FDG PET (2), where the level of metabolic activity can be used to decide whether a histological evaluation is required. Several techniques have been described to localize rib lesions for biopsy (3) such as wire-guided biopsies, intraoperative osteoscintigraphy, preoperative skin marking based on bone scan (rib counting), CT-guided biopsy, or preoperative methylene blue staining. Each of these have limitations and all are less than 100 % sensitive and accurate.
In connection with appearance of the sentinel lymph node localization technique a hand-held gamma probe has been commercially available. Afterwards, a simple technique for localization of bone metastases guided by the gamma probe intraoperatively was described (4) . The technique has been used to obtain biopsies from the ribs, sternum, pubis and cranium (1, 3, (5) (6) (7) (8) . Reports on the technique, which deserves widespread attention, originate from three American centres and are published in American literature exclusively. Consequently, we report our early experiences with intraoperative gamma probe directed rib biopsies and present some modifications of the biopsy technique.
MATERIAL AND METHODS

CLINICAL FINDINGS
Two patients with clinically and mammographically malignant tumours in the breast and lymph nodes suspected of malignancy in the armpits were seen within one month. Needle biopsy confirmed malignancy. Both patients complained of tenderness in the thoracic wall and bone scintigraphies were performed.
In the first patient bone scintigraphy showed abnormal tracer activity laterally in left seventh rib and posteriorly in eighth and ninth ribs on the right side ( Figure 1 ). X-ray of the thoracic wall and later on CT-scan showed destruction of seventh rib on the left side and five mm destruc- tion in ninth rib on the right side. In the second patient bone scintigraphy showed abnormal tracer activity as a single hot spot posteriorly in the ninth right rib. A slightly increased tracer activity in the right hip joint was considered to be on a degenerative basis ( Figure 2 ).
The findings in both cases were conferred with the oncologists and it was decided that histological diagnosis of the abnormal hot spots in the ribs was mandatory for the decision of chemotherapy.
RADIOISOTOPE-GUIDED BIOPSY
On the day of open biopsy each patient received a standard dosage for a radioisotope bone scan: 700 MBq of 99m Tcoxidronate (TechneScan ® HDP; Mallinckrodt Medical B.V., Petten, Holland). In addition to the scintigraphy the nuclear phycisian marked the position of the hot spots on the skin. Three hours later, surgical biopsies were taken. At first, the areas of interest were scanned with the hand-held gamma probe (Neoprobe, Ethicon Endosurgery, Johnson & Johnson, Cincinnatti, Ohio, USA). During recording of the tracer activity it was necessary to cover the tip of the gamma probe with the collimator supplied with the probe. The positions of maximal tracer activity were marked on the skin indicating the site of the incision. Patient no. 1 was operated on in the supine position and patient no. 2 in the left lateral position. In both cases it was noted, that the skin marks drawn in the department of nuclear medicine, with the patient in another position, now were placed in a distance of two and five cm's from the site of the incision. The length of the incision was five to six cm. The surface of the rib was dissected free and in both cases it was grossly normal. Again, with the gamma probe it was possible to determine the exact location of the target area easily, as the radioactivity within a distance of two cm's along the rib surface changed with a factor five to ten. The biopsy of the rib was taken with a four mm dermal biopsy punch needle (Miltex GmbH, D-78532 Tuttlingen, Germany). In patient no. 1 two punch biopsies were taken. In patient no. 2 only a single punch biopsy was taken. Afterwards, a fine needle aspiration biopsy of the rib marrow was obtained through the punched opening in the cortex. The postoperative courses were uneventful. In the first patient the final diagnosis was metastasis from a breast carcinoma and in addition the cytology was malign. In patient no. 2 the punch biopsy did not reveal malignant tissue, but showed abnormal structure of the bone with confluent osseous trabeculas and abnormal fibrous tissue with an increased amount of vessels. The pathologist concluded that the findings were typical for a zone close to a malignant tumour. The cytology confirmed malignancy.
DISCUSSION
The described technique is simple, sensitive and accurate. Today, in departments treating patients with breast cancers or melanomas the sentinel node technique is a rutine procedure and the surgeons are confident with the use of hand-held gamma probes. For practical reasons, we performed the bone scintigraphy three hours pre-operatively instead of six hours interval as reported in the literature. Consequently, there was a high background activity at the time of the biopsy procedure, but with the collimator mounted on the tip of the probe localization of the target area was easy. It was found very useful that the gamma probe could be adjusted to register radioactivity only when the activity was higher than the background activity (the background count mode). Furthermore, we would like to draw attention to the dermal punch biopsy needle as specially suited for biopsy of the ribs. In most cases in the literature subperiostal resections of a part of the rib has been performed. In addition to the resections, pneumothorax was reported postoperatively in a few cases. With the punch needle the surgeon was able to adjust dept of the punch exactly and thereby to biopsy the outer part of the rib, exclusively. Thereby, the risk of pneumothorax was reduced. The punch biopsies contained osseous tissue and decalcination was necessary during the preparation for histology. Consequently the time for histological diagnosis was prolonged by two days, which was insignificant from a clinical point of view. The combination of punch biopsy and fine needle aspiration cytology through the punch opening was found to be very useful.
CONCLUSION
Radioisotope-guided surgical biopsy of costal metastases is a simple and accurate technique and represents a step forward with respect to correct staging of patients suspected of a metastatic disease. With growing experience in the method it could be speculated that the future method could be practised as a percutaneous biopsy procedure in local analgesia.
